Belgium· BE-AMP-SAM056454-00
Terramycine + Polymyxine B 5 mg/g - 10000 IU/g
A oxytetracycline product containing polymyxin b sulfate, registered in Belgium by Pfizer. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Oxytetracycline is registered in 5 of 19 countries.
Countries holding a registration under ATC D06AA03 (oxytetracycline), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Oxytetracycline · ATC D06AA03
5 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Norwayprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Polymyxin B Sulfate
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- D06AA03
- ATC class
- Oxytetracycline
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0132472
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxytetracycline in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPolymyxin BSagent Pharmaceuticals
- GermanyPolymyxin B Sulfat Smartpractice EuropeSmartpractice Europe Gmbh
- United KingdomNeosporin eye dropsPLIVA Pharma Ltd
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Polymyxin B Sulfat Smartpractice Europe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf7bebdc-ce2a-4e85-a059-e8ad22440e08 GET /v1/drugs/cf7bebdc-ce2a-4e85-a059-e8ad22440e08?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye ointment",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Terramycine + Polymyxine B 5 mg/g - 10000 IU/g",
"name_fr": "Terramycine + Polymyxine B 5 mg/g - 10000 IU/g",
"name_nl": "Terramycine + Polymyxine B 5 mg/g - 10000 IU/g",
"amp_code": "SAM056454-00",
"strengths": [
"10000.0000",
"5.0000"
],
"pack_count": 1,
"substances": [
"Polymyxin B Sulfate",
"Polymyxin B",
"Oxytetracycline Hydrochloride",
"Oxytetracycline"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Oxytetracycline",
"authorisation_numbers": [
"BE056454"
]
}See everything about oxytetracycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.